Citations (42)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Chiao-Fang Teng, Tsai-Chung Li, Ting Wang, Tzu-Hua Wu, John Wang, Han-Chieh Wu, Woei-Cherng Shyu, Ih-Jen Su & Long-Bin Jeng. (2020) Increased Expression of Programmed Death Ligand 1 in Hepatocellular Carcinoma of Patients with Hepatitis B Virus Pre-S2 Mutant. Journal of Hepatocellular Carcinoma 7, pages 385-401.
Read now
Read now
Hee-Sun Hwang, A-Reum Han, Ji Yoon Lee, Gyeong Sin Park, Woo-Sung Min & Hee-Je Kim. (2019) Enhanced Anti-Leukemic Effects through Induction of Immunomodulating Microenvironment by Blocking CXCR4 and PD-L1 in an AML Mouse Model. Immunological Investigations 48:1, pages 96-105.
Read now
Read now
Stephanie R. Jackson, Melissa M. Berrien-Elliott, Jennifer M. Meyer, E. John Wherry & Ryan M. Teague. (2013) CD8+ T Cell Exhaustion During Persistent Viral Infection is Regulated Independently of the Virus-Specific T Cell Receptor. Immunological Investigations 42:3, pages 204-220.
Read now
Read now
Articles from other publishers (39)
Jing Li, Yan Zhang & Bing Luo. (2023) The programed death‐1/programed death ligand‐1 axis and its potential as a therapeutic target for virus‐associated tumours. Reviews in Medical Virology.
Crossref
Crossref
Lucile Dumolard, Caroline Aspord, Patrice N. Marche & Zuzana Macek Jilkova. (2023) Immune checkpoints on T and NK cells in the context of HBV infection: Landscape, pathophysiology and therapeutic exploitation. Frontiers in Immunology 14.
Crossref
Crossref
Siyu Li, Na Li, Shanru Yang, Haiyan Deng, Yanguo Li, Yixuan Wang, Jiaqiang Yang, Jiaxin Lv, Lan Dong, Guansen Yu, Xin Hou & Geng Wang. (2022) The study of immune checkpoint inhibitors in chronic hepatitis B virus infection. International Immunopharmacology 109, pages 108842.
Crossref
Crossref
Marion Delphin, Manon Desmares, Svenja Schuehle, Mathias Heikenwalder, David Durantel & Suzanne Faure‐Dupuy. (2021) How to get away with liver innate immunity? A viruses’ tale. Liver International 41:11, pages 2547-2559.
Crossref
Crossref
V. E. Mukhin, Yu. S. Konstantinova, R. R. Gimadiev & N. V. Mazurchik. (2021) Horizons of development of immunotherapy for malignant liver tumors. Experimental and Clinical Gastroenterology:7, pages 81-89.
Crossref
Crossref
Velislava Terzieva, Yordanka Uzunova, Radosvet Gornev & Lubomir Spassov. 2021. Organ Donation and Transplantation. Organ Donation and Transplantation.
Sama Rezasoltani, Abbas Yadegar, Hamid Asadzadeh Aghdaei & Mohammad Reza Zali. (2020) Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors. Cancer Medicine 10:3, pages 1141-1154.
Crossref
Crossref
Morvarid Golrokh Mofrad, Donya Taghizadeh Maleki & Ebrahim Faghihloo. (2020) The roles of programmed death ligand 1 in virus-associated cancers. Infection, Genetics and Evolution 84, pages 104368.
Crossref
Crossref
Lin Jiao, Jie Chen, Xiaojuan Wu, Bei Cai, Zhenzhen Su & Lanlan Wang. (2020)
Correlation of CpG methylation of the
Pdcd1
gene with PD‐1 expression on CD8
+
T cells and medical laboratory indicators in chronic hepatitis B infection
. The Journal of Gene Medicine 22:2.
Crossref
Crossref
Hsiang-Ling Ho, Teh-Ying Chou, Shung-Haur Yang, Jeng-Kai Jiang, Wei-Shone Chen, Yee Chao & Hao-Wei Teng. (2019) PD-L1 is a double-edged sword in colorectal cancer: the prognostic value of PD-L1 depends on the cell type expressing PD-L1. Journal of Cancer Research and Clinical Oncology 145:7, pages 1785-1794.
Crossref
Crossref
Chunguo Cui, Bo Yu, Qi Jiang, Xingfang Li, Kaiyao Shi & Zecheng Yang. (2018)
The roles of
PD
‐1/
PD
‐L1 and its signalling pathway in gastrointestinal tract cancers
. Clinical and Experimental Pharmacology and Physiology 46:1, pages 3-10.
Crossref
Crossref
Suzanne Faure-Dupuy, David Durantel & Julie Lucifora. (2018) Liver macrophages: Friend or foe during hepatitis B infection?. Liver International 38:10, pages 1718-1729.
Crossref
Crossref
Cheng Sun, Peixiang Lan, Qiuju Han, Mei Huang, Zhihong Zhang, Geliang Xu, Jiaxi Song, Jinyu Wang, Haiming Wei, Jian Zhang, Rui Sun, Cai Zhang & Zhigang Tian. (2018) Oncofetal gene SALL4 reactivation by hepatitis B virus counteracts miR-200c in PD-L1-induced T cell exhaustion. Nature Communications 9:1.
Crossref
Crossref
Yiming Wang, Rena Ma, Fang Liu, Seul A. Lee & Li Zhang. (2018) Modulation of Gut Microbiota: A Novel Paradigm of Enhancing the Efficacy of Programmed Death-1 and Programmed Death Ligand-1 Blockade Therapy. Frontiers in Immunology 9.
Crossref
Crossref
Pan-Liang Wang, Jun Wang, Ying Zhou, Xiao-Song Chen, Ke-Jun Zhou, Jie Wen, Jian-Jun Zhang & Wei Cai. (2017) Expression of programmed death-1 and its ligands in the liver of biliary atresia. World Journal of Pediatrics 13:6, pages 604-610.
Crossref
Crossref
Zi-Yi HuangPing XuJian-Hua LiChen-Hua ZengHua-Feng SongHui ChenYi-Bei ZhuYing-Ying SongHan-Lin LuChun-Ping ShenXue-Guang ZhangMei-Ying WuXue-Feng Wang. (2017)
Clinical Significance of Dynamics of Programmed Death Ligand-1 Expression on Circulating CD14
+
Monocytes and CD19
+
B Cells with the Progression of Hepatitis B Virus Infection
. Viral Immunology 30:3, pages 224-231.
Crossref
Crossref
P Guha, J Reha & S C Katz. (2016) Immunosuppression in liver tumors: opening the portal to effective immunotherapy. Cancer Gene Therapy 24:3, pages 114-120.
Crossref
Crossref
Edward N. Harris & Justin L. Mott. 2017. Molecules, Systems and Signaling in Liver Injury. Molecules, Systems and Signaling in Liver Injury
1
21
.
Andrea Kristina Horst, Katrin Neumann, Linda Diehl & Gisa Tiegs. (2016) Modulation of liver tolerance by conventional and nonconventional antigen-presenting cells and regulatory immune cells. Cellular & Molecular Immunology 13:3, pages 277-292.
Crossref
Crossref
Louisa Mezache, Bernard Paniccia, Angelique Nyinawabera & Gerard J Nuovo. (2015) Enhanced expression of PD L1 in cervical intraepithelial neoplasia and cervical cancers. Modern Pathology 28:12, pages 1594-1602.
Crossref
Crossref
Guoyu Zhang, Na Li, Zhu Li, Qianqian Zhu, Fang Li, Cuiling Yang, Qunying Han, Yi Lv, Zhihua Zhou & Zhengwen Liu. (2015)
microRNA-4717 differentially interacts with its polymorphic target in the
PD1
3′ untranslated region: A mechanism for regulating PD-1 expression and function in HBV-associated liver diseases
. Oncotarget 6:22, pages 18933-18944.
Crossref
Crossref
Shao-fei Wu, Wen-jing Wang & Yue-qiu Gao. (2015) Natural killer cells in hepatitis B virus infection. The Brazilian Journal of Infectious Diseases 19:4, pages 417-425.
Crossref
Crossref
Karl J. Staples, Ben Nicholas, Richard T. McKendry, C. Mirella Spalluto, Joshua C. Wallington, Craig W. Bragg, Emily C. Robinson, Kirstin Martin, Ratko Djukanović & Tom M. A. Wilkinson. (2015) Viral Infection of Human Lung Macrophages Increases PDL1 Expression via IFNβ. PLOS ONE 10:3, pages e0121527.
Crossref
Crossref
Shufeng Li, Wensheng Liao, Meng Chen, Shiying Shan, Yuanlin Song, Shuzhen Zhang, Haihan Song & Zhen Yuan. (2013) Expression of Programmed Death-1 (PD-1) on CD4+ and CD8+ T cells in Rheumatoid Arthritis. Inflammation 37:1, pages 116-121.
Crossref
Crossref
Noelle A Hutchins, Fei Wang, Yvonne Wang, Chun-Shiang Chung & Alfred Ayala. (2013) Kupffer cells potentiate liver sinusoidal endothelial cell injury in sepsis by ligating programmed cell death ligand-1. Journal of Leukocyte Biology 94:5, pages 963-970.
Crossref
Crossref
Lauren A Licata, Cang T Nguyen, Rachel A Burga, Vincent Falanga, N Joseph Espat, Alfred Ayala, Mitchell Thorn, Richard P Junghans & Steven C Katz. (2013) Biliary obstruction results in PD-1-dependent liver T cell dysfunction and acute inflammation mediated by Th17 cells and neutrophils. Journal of Leukocyte Biology 94:4, pages 813-823.
Crossref
Crossref
Zhu Li, Na Li, Qianqian Zhu, Guoyu Zhang, Qunying Han, Pingping Zhang, Meng Xun, Yawen Wang, Xiaoyan Zeng, Cuiling Yang & Zhengwen Liu. (2013) Genetic variations of PD1 and TIM3 are differentially and interactively associated with the development of cirrhosis and HCC in patients with chronic HBV infection. Infection, Genetics and Evolution 14, pages 240-246.
Crossref
Crossref
Dayan Cao, Huan Xu, Guoning Guo, Zhihua Ruan, Lei Fei, Zhunyi Xie, Yuzhang Wu & Yongwen Chen. (2012) Intrahepatic Expression of Programmed Death-1 and its Ligands in Patients with HBV-Related Acute-on-Chronic Liver Failure. Inflammation 36:1, pages 110-120.
Crossref
Crossref
Guoning Guo, Dayan Cao, Huan Xu, Zhihua Ruan, Lei Fei, Zhunyi Xie, Yuzhang Wu & Yongwen Chen. (2012) The characteristic expression of B7-H3 and B7-H4 in liver biopsies from patients with HBV-related acute-on-chronic liver failure. Pathology International 62:10, pages 665-674.
Crossref
Crossref
Horng-Tay Tzeng, Hwei-Fang Tsai, Hsiu-Jung Liao, Yi-Jiun Lin, Lieping Chen, Pei-Jer Chen & Ping-Ning Hsu. (2012) PD-1 Blockage Reverses Immune Dysfunction and Hepatitis B Viral Persistence in a Mouse Animal Model. PLoS ONE 7:6, pages e39179.
Crossref
Crossref
Xue-Ping NanYe ZhangHai-Tao YuRui-Lin SunMei-Juan PengYu LiWen-Jing SuJian-Qi LianJiu-Ping WangXue-Fan Bai. (2012)
Inhibition of Viral Replication Downregulates CD4
+
CD25
high
Regulatory T Cells and Programmed Death-Ligand 1 in Chronic Hepatitis B
. Viral Immunology 25:1, pages 21-28.
Crossref
Crossref
Man Li, Xue-Hua Sun, Xiao-Jun Zhu, Shu-Gen Jin, Zhen-Jun Zeng, Zhen-Hua Zhou, Zhuo Yu & Yue-Qiu Gao. (2012) HBcAg induces PD-1 upregulation on CD4+T cells through activation of JNK, ERK and PI3K/AKT pathways in chronic hepatitis-B-infected patients. Laboratory Investigation 92:2, pages 295-304.
Crossref
Crossref
Jordan S. Pober & George Tellides. (2012) Participation of blood vessel cells in human adaptive immune responses. Trends in Immunology 33:1, pages 49-57.
Crossref
Crossref
Wei Yang. (2012) Some research advances of immune mechanism during infection in China. Science China Life Sciences 54:12, pages 1153-1155.
Crossref
Crossref
Guoyu Zhang, Zhu Li, Qunying Han, Na Li, Qianqian Zhu, Fang Li, Yi Lv, Jinghong Chen, Sai Lou & Zhengwen Liu. (2011) Altered TNF-α and IFN-γ levels associated with PD1 but not TNFA polymorphisms in patients with chronic HBV infection. Infection, Genetics and Evolution 11:7, pages 1624-1630.
Crossref
Crossref
Zhen Zeng, Feng Shi, Lin Zhou, Min-Na Zhang, Yan Chen, Xiu-Juan Chang, Yin-Ying Lu, Wen-Lin Bai, Jian-Hui Qu, Chun-Ping Wang, Hong Wang, Min Lou, Fu-Sheng Wang, Ji-Yun Lv & Yong-Ping Yang. (2011) Upregulation of Circulating PD-L1/PD-1 Is Associated with Poor Post-Cryoablation Prognosis in Patients with HBV-Related Hepatocellular Carcinoma. PLoS ONE 6:9, pages e23621.
Crossref
Crossref
Marta Rodríguez-García, Filippos Porichis, Olivier G de Jong, Karen Levi, Thomas J Diefenbach, Jeffrey D Lifson, Gordon J Freeman, Bruce D Walker, Daniel E Kaufmann & Daniel G Kavanagh. (2011) Expression of PD-L1 and PD-L2 on human macrophages is up-regulated by HIV-1 and differentially modulated by IL-10. Journal of Leukocyte Biology 89:4, pages 507-515.
Crossref
Crossref
Kate McKeage & Susan J. Keam. (2010) Telbivudine. Drugs 70:14, pages 1857-1883.
Crossref
Crossref
Sheng Guo, Chengying Yang, Feng Mei, Shengxi Wu, Na Luo, Lei Fei, Yongwen Chen & Yuzhang Wu. (2010) Down-regulation of Z39Ig on macrophages by IFN-γ in patients with chronic HBV infection. Clinical Immunology 136:2, pages 282-291.
Crossref
Crossref